Roche Holding AG (RHHBF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 09:44AM EDT
| Previous Close | 263.00 |
| Open | 252.37 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 252.37 - 269.50 |
| 52 Week Range | 243.42 - 354.00 |
| Volume | |
| Avg. Volume | 201 |
| Market Cap | 188.264B |
| Beta (5Y Monthly) | 0.15 |
| PE Ratio (TTM) | 16.24 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 10.86 (4.13%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | N/A |
- Zacks
Roche (RHHBY) Alecensa Wins FDA Nod for Label Expansion
Roche (RHHBY) has won FDA approval for Alecensa as an adjuvant treatment, following tumor resection for patients with ALK-positive non-small cell lung cancer.
- Zacks
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.
- Zacks
Adaptimmune (ADAP) Down on End of Collaboration With Roche
Adaptimmune's (ADAP) shares plummet as the company;s collaboration to develop and commercialize allogeneic cell therapies with Roche gets terminated.
© 2024 Yahoo. All rights reserved.